NCT00497809 Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia Status COMPLETED Phase PHASE2
NCT00445497 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Status UNKNOWN Phase PHASE3
NCT00364468 Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients Status COMPLETED Phase PHASE2
NCT00352300 Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer Status COMPLETED Phase PHASE1
NCT00335478 Daptomycin in Treating Neutropenia and Fever in Patients With Cancer Status COMPLETED Phase PHASE2
NCT00296049 Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy Status WITHDRAWN Phase NA
NCT00277160 A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer Status COMPLETED Phase PHASE4
NCT00260689 Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia Status COMPLETED Phase PHASE2
NCT00194857 Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin Status TERMINATED Phase PHASE4
NCT00174473 A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children Status COMPLETED Phase PHASE1/PHASE2
NCT00138736 Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia Status COMPLETED Phase PHASE2
NCT00129688 Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children Status COMPLETED Phase NA
NCT00125723 FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy Status COMPLETED Phase PHASE4
NCT00115414 Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) Status COMPLETED Phase PHASE2
NCT00107081 Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting Status TERMINATED Phase PHASE3
NCT00082537 MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) Status COMPLETED Phase PHASE2
NCT00077311 Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00068471 Anidulafungin in Treating Immunocompromised Children With Neutropenia Status COMPLETED Phase PHASE1/PHASE2